Litigation Details for CELGENE CORPORATION v. APOTEX INC. (D.N.J. 2018)
✉ Email this page to a colleague
CELGENE CORPORATION v. APOTEX INC. (D.N.J. 2018)
| Docket | ⤷ Sign Up | Date Filed | 2018-01-11 |
| Court | District Court, D. New Jersey | Date Terminated | 2021-03-10 |
| Cause | 15:1126 Patent Infringement | Assigned To | Susan Davis Wigenton |
| Jury Demand | None | Referred To | Leda Dunn Wettre |
| Patents | 6,045,501; 6,315,720; 6,561,976; 6,561,977; 6,755,784; 6,869,399; 7,141,018; 7,468,363; 7,855,217; 7,959,566; 8,315,886; 8,626,531; 8,741,929 | ||
| Firms | Quinn Emanuel Uquhart & Sullival LLP | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in CELGENE CORPORATION v. APOTEX INC.
Details for CELGENE CORPORATION v. APOTEX INC. (D.N.J. 2018)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2018-01-10 | 1 | 6,045,501 * 4/2000 Elsayed et al. ..............… from the In this regard, U.S. Pat. No. 6,045,501, to Elsayed et al., 65 patient, which… 6,045,501 A * 4/2000 Elsayed et al. ..........… In this regard, U.S. Pat. No. 6,045,501, to Elsayed et al., PATIENT WHILE RESTRICTING… 6,045,501 A * 4/2000 Elsayed et al. .......... | External link to document | |
| 2019-04-30 | 63 | including in connection with proceedings on U.S. Patent No. 7,855,217; this court retains jurisdiction to enforce…211022 infringes claim numbers 1-10 of U.S. Patent No. 7,855,217 (“Asserted Claims”) (see D.I. 1): …including in connection with proceedings on U.S. Patent No. 7,855,217. 8. This court retains jurisdiction…Celgene as to Count VII (Infringement of the ‘217 Patent) of Celgene’s Complaint(D.l. l); … 5. Count VII (Infringement of the ‘217 Patent) of Celgene’s Complaint (D.I. 1) is hereby dismissed | External link to document | |
| 2019-05-08 | 65 | BIFURCATION AND STAY WITH RESPECT TO U.S. PATENT NOS. 6,315,720, 6,561,977, 6,755,784, 8,315,886, AND 8,…REMS Patents shall be bifurcated from all claims and defenses with respect to the Remaining Patents-in-… and all other proceedings related to the REMS Patents shall be stayed; notwithstanding the foregoing,…2018 10 March 2021 2:18-cv-00461 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
